GI Partners, a leading private investment firm, announces it has completed the acquisition of the Contract Development and Manufacturing Organization (CDMO) and Cell Solutions businesses from Charles River Laboratories International, Inc., forming Rose BioSolutions (“Rose Bio”), a leading provider of advanced manufacturing capabilities across the cell and gene therapy space. As an independent company, Rose Bio is purpose-built to deliver end-to-end advanced therapy solutions for clients, providing CDMO’s full-service development and manufacturing capabilities across plasmid DNA, viral vector, and cell therapy capabilities, as well as Cell Solutions’ ability to deliver the cellular materials that research and advanced therapies depend on.
Read the full article: GI Partners Completes Acquisition of the CDMO and Cell Solutions Businesses from Charles River Laboratories and Forms Rose BioSolutions //
Source: https://www.prnewswire.com/news-releases/gi-partners-completes-acquisition-of-the-cdmo-and-cell-solutions-businesses-from-charles-river-laboratories-and-forms-rose-biosolutions-302765625.html